Literature DB >> 28119485

Plasma Cytokines and Chemokines in Zambian Children With Measles: Innate Responses and Association With HIV-1 Coinfection and In-Hospital Mortality.

Wen-Hsuan W Lin1, Ashley N Nelson1, Judith J Ryon1, William J Moss1,2, Diane E Griffin1.   

Abstract

To identify immune factors present during the acute rash phase of measles and associations with outcome and human immunodeficiency virus type 1 (HIV-1) coinfection, we measured the plasma levels of 22 cytokines and chemokines in Zambian children hospitalized with measles (n = 148) and control children (n = 44). Children with measles had higher levels of innate cytokines tumor necrosis factor (TNF) α, interleukin 1β (IL-1β), interleukin 18, and interleukin 6; chemokines CCL2, CCL4, CCL11, CCL22, CXCL8, and CXCL10; and T-cell cytokines interferon γ, and interleukin 2, 10, and 17. Children who died in the hospital had higher levels of TNF-α, IL-1β, interleukin 12p70; CCL2, CCL4, CCL13, CCL17, CXCL8, CXCL10; and interleukin 2 and interferon γ than children who survived, and lower levels of interleukin 4. Children coinfected with HIV-1 had higher levels of TNF-α and IL-1β than HIV-uninfected children with measles, and lower levels of interleukin 4 and 5. Therefore, acute measles was characterized by activation of macrophages and T cells producing type 1, but not type 2, cytokines, which was more pronounced in fatal disease.
© The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  NF-κB; innate responses; macrophage activation; measles; inflammasome

Mesh:

Substances:

Year:  2017        PMID: 28119485      PMCID: PMC5388292          DOI: 10.1093/infdis/jix012

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  50 in total

1.  Comparative analysis of host responses related to immunosuppression between measles patients and vaccine recipients with live attenuated measles vaccines.

Authors:  H Okada; T A Sato; A Katayama; K Higuchi; K Shichijo; T Tsuchiya; N Takayama; Y Takeuchi; T Abe; N Okabe; M Tashiro
Journal:  Arch Virol       Date:  2001       Impact factor: 2.574

Review 2.  The interleukin-1 family: back to the future.

Authors:  Cecilia Garlanda; Charles A Dinarello; Alberto Mantovani
Journal:  Immunity       Date:  2013-12-12       Impact factor: 31.745

Review 3.  Transcriptional control of the TNF gene.

Authors:  James V Falvo; Alla V Tsytsykova; Anne E Goldfeld
Journal:  Curr Dir Autoimmun       Date:  2010-02-18

4.  High attack rates and case fatality during a measles outbreak in groups with religious exemption to vaccination.

Authors:  D V Rodgers; J S Gindler; W L Atkinson; L E Markowitz
Journal:  Pediatr Infect Dis J       Date:  1993-04       Impact factor: 2.129

5.  Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C.

Authors:  David Butera; Svetlana Marukian; Amy E Iwamaye; Edgardo Hembrador; Thomas J Chambers; Adrian M Di Bisceglie; Edgar D Charles; Andrew H Talal; Ira M Jacobson; Charles M Rice; Lynn B Dustin
Journal:  Blood       Date:  2005-04-28       Impact factor: 22.113

6.  Measles virus V protein inhibits NLRP3 inflammasome-mediated interleukin-1β secretion.

Authors:  Noritaka Komune; Takeshi Ichinohe; Minako Ito; Yusuke Yanagi
Journal:  J Virol       Date:  2011-10-12       Impact factor: 5.103

7.  Limited in vivo production of type I or type III interferon after infection of macaques with vaccine or wild-type strains of measles virus.

Authors:  Rupak Shivakoti; Debra Hauer; Robert J Adams; Wen-Hsuan W Lin; William Paul Duprex; Rik L de Swart; Diane E Griffin
Journal:  J Interferon Cytokine Res       Date:  2014-12-17       Impact factor: 2.607

8.  Immune activation in measles.

Authors:  D E Griffin; B J Ward; E Jauregui; R T Johnson; A Vaisberg
Journal:  N Engl J Med       Date:  1989-06-22       Impact factor: 91.245

Review 9.  Critical functions of priming and lysosomal damage for NLRP3 activation.

Authors:  Veit Hornung; Eicke Latz
Journal:  Eur J Immunol       Date:  2010-03       Impact factor: 5.532

10.  Clinical aspects and cytokine response in severe H1N1 influenza A virus infection.

Authors:  Natalia Hagau; Adriana Slavcovici; Daniel N Gonganau; Simona Oltean; Dan S Dirzu; Erika S Brezoszki; Mihaela Maxim; Constantin Ciuce; Monica Mlesnite; Rodica L Gavrus; Carmen Laslo; Radu Hagau; Magda Petrescu; Daniela M Studnicska
Journal:  Crit Care       Date:  2010-11-09       Impact factor: 9.097

View more
  7 in total

1.  Measles Virus Infects and Programs MAIT Cells for Apoptosis.

Authors:  Patrick T Rudak; Tony Yao; Christopher D Richardson; S M Mansour Haeryfar
Journal:  J Infect Dis       Date:  2021-02-24       Impact factor: 5.226

Review 2.  Understanding the causes and consequences of measles virus persistence.

Authors:  Diane E Griffin; Wen-Hsuan W Lin; Ashley N Nelson
Journal:  F1000Res       Date:  2018-02-28

3.  Persistent high plasma levels of sCD163 and sCD14 in adult patients with measles virus infection.

Authors:  Claudia Mascia; Irene Pozzetto; Blerta Kertusha; Raffaella Marocco; Cosmo Del Borgo; Tiziana Tieghi; Serena Vita; Stefano Savinelli; Marco Iannetta; Vincenzo Vullo; Miriam Lichtner; Claudio Maria Mastroianni
Journal:  PLoS One       Date:  2018-05-24       Impact factor: 3.240

4.  Helicobacter pylori Reactivates Human Immunodeficiency Virus-1 in Latently Infected Monocytes with Increased Expression of IL-1β and CXCL8.

Authors:  Vidhya Natarajan; Preeti Moar; Urvinder S Kaur; Vimala Venkatesh; Abhishek Kumar; Rupesh Chaturvedi; D Himanshu; Ravi Tandon
Journal:  Curr Genomics       Date:  2019-12       Impact factor: 2.236

5.  A durable protective immune response to wild-type measles virus infection of macaques is due to viral replication and spread in lymphoid tissues.

Authors:  Wen-Hsuan W Lin; Eileen Moran; Robert J Adams; Robert E Sievers; Debra Hauer; Steven Godin; Diane E Griffin
Journal:  Sci Transl Med       Date:  2020-04-01       Impact factor: 17.956

6.  Evolution of T Cell Responses during Measles Virus Infection and RNA Clearance.

Authors:  Ashley N Nelson; Nicole Putnam; Debra Hauer; Victoria K Baxter; Robert J Adams; Diane E Griffin
Journal:  Sci Rep       Date:  2017-09-13       Impact factor: 4.379

Review 7.  Measles immunity and immunosuppression.

Authors:  Diane E Griffin
Journal:  Curr Opin Virol       Date:  2020-09-04       Impact factor: 7.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.